XML 25 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities      
Net income $ 61,807,000 $ 67,800,000 $ 75,948,000
Proceeds from sales of loans held for sale 174,759,000 157,213,000 103,347,000
Originations of loans held for sale (171,757,000) (155,995,000) (95,007,000)
Items not requiring (providing) cash      
Depreciation 8,238,000 8,723,000 8,498,000
Amortization 712,000 589,000 1,179,000
Compensation expense for stock option grants 1,770,000 1,621,000 1,437,000
Provision for credit losses 1,700,000 2,250,000 3,000,000
Provision (credit) for unfunded commitments 1,016,000 (5,329,000) 3,187,000
Net gain on loan sales (3,779,000) (2,354,000) (2,584,000)
Net realized loss on available-for-sale securities 0 0 130,000
Loss (gain) on sale of premises and equipment (43,000) 26,000 (1,023,000)
Loss (gain) on sale/write-down of other real estate and repossessions (496,000) 39,000 (126,000)
Accretion of deferred income, premiums, discounts and other (14,337,000) (13,774,000) (15,842,000)
Loss (gain) on derivative interest rate products 58,000 337,000 (321,000)
Net non-cash gain recorded on contract termination (2,762,000) 0 0
Deferred income taxes 457,000 2,985,000 2,485,000
Changes in      
Interest receivable 776,000 (2,099,000) (8,402,000)
Prepaid expenses and other assets (178,000) (4,543,000) 2,141,000
Accrued expenses and other liabilities (12,847,000) 23,470,000 5,637,000
Income taxes refundable/payable (1,030,000) (259,000) 1,162,000
Net cash provided by operating activities 44,064,000 80,700,000 84,846,000
Investing Activities      
Net change in loans (78,098,000) (79,096,000) (134,344,000)
Purchase of loans (26,251,000) (400,000) (361,817,000)
Purchase of premises and equipment (4,924,000) (7,300,000) (20,110,000)
Proceeds from sale of premises and equipment 164,000 254,000 3,980,000
Proceeds from sale of other real estate and repossessions 1,706,000 313,000 2,351,000
Proceeds from sale of available-for-sale securities 0 0 18,375,000
Proceeds from repayments of held-to-maturity securities 7,318,000 7,228,000 23,821,000
Proceeds from maturities, calls and repayments of available-for-sale securities 31,470,000 26,888,000 51,348,000
Purchase of available-for-sale securities (92,631,000) (5,436,000) (360,725,000)
Investment in tax credit partnerships (12,069,000) (35,160,000) (18,266,000)
Redemption (purchase) of Federal Home Loan Bank stock and other interest-earning assets (2,079,000) 4,501,000 (24,159,000)
Net cash used in investing activities (175,394,000) (88,208,000) (819,546,000)
Financing Activities      
Net increase (decrease) in certificates of deposit (61,732,000) 26,806,000 321,718,000
Net increase (decrease) in checking and savings accounts (54,315,000) 9,856,000 (188,909,000)
Net increase in short-term borrowings and other interest-bearing liabilities 75,238,000 57,027,000 127,471,000
Proceeds from borrowing under Federal Reserve Bank Term Funding Program 180,000,000 0 0
Advances from (to) borrowers for taxes and insurance 326,000 (1,644,000) 443,000
Purchase of the company's common stock (15,152,000) (23,326,000) (61,847,000)
Dividends paid (18,708,000) (19,282,000) (19,181,000)
Stock options exercised 10,096,000 884,000 6,258,000
Net cash provided by financing activities 115,753,000 50,321,000 185,953,000
Increase (Decrease) in Cash and Cash Equivalents (15,577,000) 42,813,000 (548,747,000)
Cash and Cash Equivalents, Beginning of Year 211,333,000 168,520,000 717,267,000
Cash and Cash Equivalents, End of Year $ 195,756,000 $ 211,333,000 $ 168,520,000